In addition, immunohistochemical staining for PD-L1 showed that higher PD-L1 expression in patients with POLE mutations than in WT patients (Figures 1I, J), suggesting a potential mechanism of immune evasion by the tumor cells. This evidence concerns the gene CD274 and neoplasm.